Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AEYE | Common Stock | Sale | -$77.5K | -5.84K | -1.3% | $13.26 | 443K | Aug 5, 2021 | CSB IV US Holdings LLC | F1, F2, F3 |
transaction | AEYE | Common Stock | Sale | -$65.9K | -4.8K | -1.08% | $13.73 | 439K | Aug 6, 2021 | CSB IV US Holdings LLC | F1, F3, F4 |
holding | AEYE | Common Stock | 18.6K | Aug 5, 2021 | Carr Bettis IRA | F5 | |||||
holding | AEYE | Common Stock | 411K | Aug 5, 2021 | Direct |
Id | Content |
---|---|
F1 | Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2021. |
F2 | Reflects the weighted average price of 5,844 shares of common stock of AudioEye, Inc. sold in multiple transactions on August 5, 2021 with sales prices ranging from $12.96 to $13.525 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F3 | Dr. Bettis is deemed to be a beneficial owner of CSB IV US Holdings LLC. |
F4 | Reflects the weighted average price of 4,800 shares of common stock of AudioEye, Inc. sold in multiple transactions on August 6, 2021 with sales prices ranging from $13.25 to $13.95 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F5 | Dr. Bettis is deemed to be a beneficial owner of Carr Bettis IRA. |